Brain+ A/S (CPH:BRAINP)
Denmark
· Delayed Price · Currency is DKK 0.0180
+0.0008 (4.44%)
May 13, 2025, 2:43 PM CET
Brain+ Revenue
In the year 2024, Brain+ had annual revenue of 7.86M DKK with 28.08% growth.
Revenue
7.86M
Revenue Growth
+28.08%
P/S Ratio
1.50
Revenue / Employee
654.88K
Employees
12
Market Cap
11.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.86M | 1.72M | 28.08% |
| Dec 31, 2023 | 6.14M | 51.21K | 0.84% |
| Dec 31, 2018 | 6.08M | 1.74M | 40.10% |
| Dec 31, 2017 | 4.34M | 2.37M | 120.05% |
| Dec 31, 2016 | 1.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 303.14B |
| Coloplast | 27.79B |
| Genmab | 21.64B |
| Demant | 22.42B |
| ALK-Abelló | 5.71B |
| Zealand Pharma | 55.69M |
| H. Lundbeck | 22.00B |
| Ambu A/S | 5.83B |